You searched for

Amitryptyline [Grindeks]

Your fellow patients have spoken – hear their voices:

The following results on this page are based on 1486 unique reviews from patients using the DrugStars app. These DrugStars users have given a Medicine Experience and Attitude (MEA) score of 62.3 in the range of -100 to +100 for Amitryptyline [Grindeks] To see how the MEA Score is calculated click here.

After the results for product Amitryptyline [Grindeks] you can add your voice below. Every voice added gets us closer to be being heard by Payers and Pharma, getting us closer to what we call Patient Powered Pharmaceuticals.

62.3

We asked patients how effective they found this medicine.

(1480 respondents)

Answers

Extremely effective (36%)
Very (35%)
Somewhat (18%)
Slightly (8%)
Very little effective (4%)

We asked patients how bothered they were by side effects with this medicine.

(1486 respondents)

Answers

Not at all bothered (50%)
Slightly (26%)
Somewhat (15%)
Very (7%)
Extremely bothered (3%)

We asked patients how often they took this medication as prescribed.

(1486 respondents)

Answers

All the time (81%)
Most of the time (13%)
Often (3%)
Sometimes (2%)
Never (0%)

We asked patients how difficult they found it to take this medicine as prescribed.

(1486 respondents)

Answers

Not at all difficult (83%)
Slightly (10%)
Somewhat (5%)
Very (1%)
Extremely difficult (1%)

We asked patients how confident they felt about taking this medicine.

(1486 respondents)

Answers

Extremely confident (44%)
Very (31%)
Somewhat (19%)
Slightly (4%)
Not at all confident (2%)

We asked patients how necessary they find this medicine.

(1462 respondents)

Answers

Extremely necessary (55%)
Very (29%)
Somewhat (11%)
Slightly (4%)
Not at all necessary (1%)

We asked patients how often they forget to take this medicine at the right time.

(1338 respondents)

Answers

Never (56%)
Rarely (27%)
Sometimes (11%)
Often (3%)
Almost all the time (2%)

We asked patients to what extent they felt the benefits outweighed any disadvantages of this medicine.

(1366 respondents)

Answers

Extremely (45%)
Large (28%)
Moderate (16%)
Small (5%)
Not at all (5%)

We asked patients how satisfied they were with the information and guidance received along with this medicine.

(1366 respondents)

Answers

Very satisfied (50%)
Satisfied (31%)
Neither dissatisfied nor satisfied (13%)
Dissatisfied (3%)
Very dissatisfied (3%)

Add your voice and help others.

If you feel that the information shown is not representative of how you feel, or you want to join the DrugStars movement, helping other patients like you then you can join DrugStars by either downloading the app and adding your medication experiences. Or you can use our webform here on the site, just click the buttons below.

Every time you review a medication you empower patients!

Popular drug reviews

Review recap

DrugsDisclosed has gathered medical insights from 1486 real-world patients taking Amitryptyline [Grindeks]. These patients are from different countries, lifestyles and healthcare systems, their unifying characteristic is the medicine they take.

1480 patients taking Amitryptyline [Grindeks] were asked how effective they found their medicine. Luckily 70% responded very positively about Amitryptyline [Grindeks] reporting that they were very / extremely effective, while 18% reported that they felt Amitryptyline [Grindeks] was only somewhat effective for them. Finally 12% of the patients asked reported that Amitryptyline [Grindeks] had only a slight or very little effect for them.

1486 patients taking Amitryptyline [Grindeks] were asked how bothered they were by any side effects from taking Amitryptyline [Grindeks]? 75% felt not at all or only slightly bothered by side effects from taking Amitryptyline [Grindeks], while 15% felt somewhat bothered. Meaning that 10% felt very or extremely bothered by side effects from taking Amitryptyline [Grindeks].

We asked 1486 patients taking Amitryptyline [Grindeks] how often they took their medicine as prescribed by their doctor? 94% said they never, or only sometimes forget, while 3% often forgot to take their Amitryptyline [Grindeks] as prescribed. This leaves 3% who sadly forgot to take their Amitryptyline [Grindeks] all the time. Taking medication at the right time is very important for your treatment. Try our free app DrugStars to help you manage your medication.

We asked 1486 patients taking Amitryptyline [Grindeks] how difficult they found it to take their medicine as prescribed? There can be many factors why they found it difficult to take as prescribed. 93% of those asked positively reported that they found it not at all or only somewhat difficult to take their Amitryptyline [Grindeks] as prescribed, whereas 5% reported that they found taking the same medication very difficult. Sadly, there were still 2% who reported finding it extremely difficult for them to take their medicine as prescribed.

A patient survey asked 1486 patients just how confident they felt about taking Amitryptyline [Grindeks]? 75% replied postivly that they felt either very or extremely confident when it came to taking Amitryptyline [Grindeks]. 19% of the patients replied they were only slightly confident, while 6% of them responded feeling only slightly confident when it came to taking Amitryptyline [Grindeks].

We asked 1462 patients how necessary they found taking Amitryptyline [Grindeks]. 84% of the patients asked found Amitryptyline [Grindeks] to be very or extremely necessary for them, while 11% found it to be only somewhat necessary. However, there are still 5% of patients using Amitryptyline [Grindeks] who feel it is only slightly or even not at all necessary for them.

1338 patients were recently asked how often they forgot to take their medication? 83% of those asked never or rarely forgot their medication, while 11% of those taking Amitryptyline [Grindeks] reported that they sometimes forgot. This left 5% of patients sadly reporting that they often or almost all the time forgot to take their medication. If you also forget your medication try using DrugStars to help you remember.

When we asked 1366 patients to what extent they felt that the benefits of their medicine outweighed its disadvantages a group of 73% of them replied that they felt to a large or even extreme extent that the advantages of taking Amitryptyline [Grindeks] outweighed any disadvantages. 16% of the patients however felt this to a moderate extent leaving 11% who felt this was true to only a small extent or even felt not at all.

When asking 1366 patients taking Amitryptyline [Grindeks] if they were satisfied with the information and guidance they received with their medication. 82% of them answered that they were very satisfied or satisfied while, 13% of were neither satisfied nor dissatisfied. That left 6% of patients feeling either dissatisfied or worse of all very dissatisfied when it came to the information and guidance they received with their Amitryptyline [Grindeks].

NO MEDICAL ADVICE OR RECOMMENDATION

The Service is solely intended as a tool to assist you in getting insights on other patients experience with a specific product.

The Service does not provide you with advice or recommendation of any kind and you should not rely upon this website as the basis for any decision or action and is not intended as and may not be relied upon as or substitute medical advice. You are advised to consult a professional advisor or doctor in the relevant field with respect to the applicability of any specific aspect of the contents, including any kind of medical advice.

The data provided do not represent scientific processed data, and is solely based on individuals subjective review. All reviews is verified with a picture during the review process on the DrugStars app.